Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

NCT00107354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: therapeutic allogeneic lymphocytes
BIOLOGICAL: therapeutic autologous lymphocytes
DRUG: cytarabine
DRUG: etoposide
DRUG: mitoxantrone hydrochloride
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Fred Hutchinson Cancer Center